BioHorizons is a leading global provider of advanced dental implant solutions and biologics designed to enhance patient care and clinical outcomes. Headquartered in Birmingham, Alabama, USA, BioHorizons is recognized for its innovative products and commitment to scientific research and education in the field of implant dentistry.
History
BioHorizons was founded in 1994 by a team of biomedical engineers from the University of Alabama at Birmingham. The company quickly gained recognition for its science-driven approach and commitment to improving dental implant technology. Over the years, BioHorizons has developed a reputation for innovation, quality, and reliability, driven by a deep understanding of biomechanics and clinical needs.
Position in the Dental Industry
BioHorizons is a prominent player in the dental implant industry, offering a comprehensive range of products that include dental implants, prosthetics, and biologics. The company’s solutions are designed to provide predictable and long-lasting results for dental professionals and their patients, addressing a wide variety of clinical indications.
Reputation
BioHorizons is renowned for its commitment to quality, innovation, and education. The company collaborates with leading dental professionals, researchers, and academic institutions to develop products that meet the highest standards of safety and efficacy. BioHorizons’ products are backed by extensive scientific research and clinical data, ensuring trust and confidence among dental practitioners.
Size and Global Presence
BioHorizons operates in over 90 countries, with a significant global footprint that includes manufacturing facilities, research and development centers, and distribution networks. The company’s headquarters in Birmingham, Alabama, is supported by additional corporate offices and distribution centers in Europe, Latin America, and Asia. BioHorizons’ extensive global presence ensures that its products and services are accessible to dental professionals and patients worldwide.
Number of Employees
As of 2023, BioHorizons employs approximately 1,000 people globally. The company’s dedicated workforce includes engineers, researchers, clinicians, and support staff who are committed to driving innovation and maintaining the highest standards of quality and service. BioHorizons fosters a culture of collaboration, continuous improvement, and professional development.
Annual Sales
BioHorizons has demonstrated strong financial performance, reflecting its leadership in the dental implant industry and the growing demand for its innovative solutions. In 2022, the company reported annual sales of approximately USD 250 million. This robust revenue growth underscores BioHorizons’ strategic vision, operational excellence, and commitment to advancing dental care.
Research and Development
BioHorizons invests significantly in research and development (R&D) to drive innovation and meet the evolving needs of dental professionals and patients. The company collaborates with leading universities, research institutions, and dental practitioners to develop new products and technologies. BioHorizons’ R&D efforts focus on enhancing the performance, reliability, and aesthetics of dental implants and related solutions.
Sustainability and Corporate Responsibility
BioHorizons is committed to sustainability and corporate social responsibility. The company implements environmentally sustainable practices throughout its operations and actively supports initiatives that promote oral health and access to dental care. BioHorizons’ commitment to ethical business practices and social responsibility is integral to its mission of improving the quality of life for patients and advancing dental care globally.
BioHorizons’ dedication to quality, innovation, and education has made it a global leader in the dental implant industry. With a rich history, a strong global presence, and a commitment to research and development, BioHorizons continues to set new benchmarks in dental care, enhancing the lives of patients and supporting dental professionals worldwide.